Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

2020449 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Hepatology

Volume 73, Issue 1, pp. 26-39

Field-Weighted Citation Impact: 42.18